Canadian Task Force on Preventive Health Care

Selected References

Preventive Health Care, 1999 Update: Use Of Ambulatory Electrocardiography For The Detection Of Paroxysmal Atrial Fibrillation In Patients With Stroke

Prepared by Chaim Bell, MD, Dept. of Medicine, University of Toronto, Institute of Medical Science, and Moira Kapral, MD, Department of Medicine, University of Toronto, Division of General Internal Medicine and Clinical Epidemiology, The Toronto Hospital

These recommendations were finalized by the Task Force in June 1999

  1. Statistics Canada, Health Canada, Heart and Stroke Foundation of Canada, editors.  Heart Disease and Stroke in Canada 1997.
  2. Statistics Canada.  Causes of death, 1993.  Cat. 84-208 (Annual).
  3. Bonita R.  Epidemiology of stroke.  Lancet 1992;339:342-347.
  4. Wigle DT, Mao Y, Wong T, Lane R.  Economic burden of illness in Canada, 1986.  Chronic Diseases in Canada 1991;Suppl 12(3):1-37.
  5. Cerebral Embolism Task Force.  Cardiogenic brain embolism: The second report of the Cerebral Embolism Task Force.  Arch Neurol 1989;46:727-743.
  6. Sherman DG, Dyken ML, Fisher M, et al.  Cerebral embolism.  Chest 1986;89 (suppl):82S-98S.
  7. Cerebral Embolism Task Force.  Cardiogenic brain embolism.  Arch Neurol 1986;43:71-84.
  8. Bharucha NE, Wolf PA, Kannel WB, et al.  Epidemiological study of cerebral embolism:  The Framingham Study, abstracted.  Ann Neuol 1981;10:105.
  9. Sherman DG, Goldman L, Whiting RB, et al.  Thromboembolism in patients with atrial fibrillation.  Arch Neurol 1984;708-710.
  10. Lin H-J, Wolf PA, Benjamin EJ, et al.  Newly diagnosed atrial fibrillation and acute stroke:  The Framingham Study.  Stroke 1995;26:1527-1530.
  11. Selzer A.  Atrial fibrillation revisited.  N Engl J Med 1982;306:1044-1045.
  12. Bougousslavsky J, Van Melle G, Regli F.  The Lausanne Stroke Registry:  Analysis of 1,000 consecutive patients with first stroke.  Stroke 1988;19:1083-1092.
  13. Woolf SH, Battista RN, Anderson GM, Logan AG, Wang E and other members of the Canadian Task Force on the Periodic Health Examination. Assessing the clinical effectiveness of preventive maneuvers: Analytic principles and systematic methods in reviewing evidence and developing clinical practice recommendations. J Clin Epidemiol 1990; 43(9): 891-905.
  14. The Stroke Prevention in Atrial Fibrillation Investigators.  Predictors of thromboembolism in atrial fibrillation:  I.  Clinical features of patients at risk.  Ann Int Med 1992;116:1-5.
  15. Atrial Fibrillation Investigators.  Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation.  Arch Intern Med 1994;154:1449-1457.
  16. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin.  JAMA 1998;279:1273-1277.
  17. Green CJ, Hadorn DC, Bassett K, Kazanjian A.  Anticoagulation in chronic nonvalvular atrial fibrillation:  A critical appraisal and meta-analysis.  Can J Cardiol 1997;13:811-815.
  18. Ezekowitz MD, Bridgers SL, James KE, et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation.  N Engl J Med 1992;327:1406-1412.
  19. EAFT Study Group.  Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke.  Lancet 1993;342:1255-1262.
  20. Gajewski J, Singer RB.  Mortality in an insured population with atrial fibrillation.  JAMA 1981;245:1540-1544.
  21. Kannel WB, Abbot RD, Savage DD, McNamara PM.  Coronary heart disease and atrial fibrillation:  The Framingham Study.  Am Heart J 1983;106:389-396.
  22. Treseder AS, Sastry BSD, Thomas TPL, et al.  Atrial fibrillation and stroke in elderly hospitalized patients.  Age and Ageing 1986;15:89-92.
  23. Takahashi N, Seki A, Imataka K, Fujii J.  Clinical features of paroxysmal atrial fibrillation.  An observation of 94 patients.  Jpn Heart J 1981;22:143-149.
  24. Shimomura K, Ohe T, Uehara S et al.  Significance of atrial fibrillation as a precursor of embolism.  Am J Cardiol 1989;63:1405-1407.
  25. Wiener I, Hafner R, Nicolai M, Lyons H.  Clinical and echocardiographic correlates of systemic embolization in nonrheumatic atrial fibrillation.  Am J Cardiol 1987;59:177.
  26. Roy D, Marchand E, Gagne P, et al.  Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation.  Am Heart J 1986;112:1039-1043.
  27. Stroke Prevention in Atrial Fibrillation Investigators.  Stroke prevention in atrial fibrillation study:  final results.  Circulation 1991;84:527-539.
  28. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators.  Effect of low-dose warfarin on the risk of stroke in patients with non-rheumatic atria fibrillation.  N Engl J Med 1990;323:1506-1511.
  29. Laupacis A, Albers GW, Dalen JE, et al.  Antithrombotic therapy in atrial fibrillation.  Chest 1995;108 (suppl):352-359S.
  30. Petersen P and Godtfredsen J.  Embolic complications in paroxysmal atrial fibrillation.  Stroke 1986;17:622-626.
  31. Auguste H, Fortin BA, Isner JM.  Should patients with paroxysmal atrial fibrillation receive prophylactic anticoagulation?  J Am Coll Cardiol 1983;1:704.
  32. Corbalan R, Arriagada D, Braun S, et al.  Risk factors for systemic embolism in patients with paroxysmal atrial fibrillation.  Am Heart J 1992;124:149-153.
  33. Lip GYH. Does paroxysmal atrial fibrillation confer a paroxysmal thromboembolic risk?  Lancet 1997;349:1565-1566.
  34. Lip GYH, Lowe GDO.  ABC of atrial fibrillation.  Antithrombotic therapy for atrial fibrillation. Br Med J 1996;312:45-49
  35. Goldstein LB, Bonito AJ, Matchar DB, et al.  US national survey of physician practices for the secondary and tertiary prevention of ischemic stroke:  Design, service availability, and common practices.  Stroke 1995;26:1607-1615.
  36. Knoebel SB, et al.  American College of Cardiology/American Heart Association.  Guidelines for ambulatory electrocardiography.  JACC 1989;13:249-258.
  37. Pratt CM, Eaton T, Francis M, Pacifico A.  Ambulatory electrocardiographic recordings:  the Holter monitor.  Curr Probl Cardiol. 1988;13:521-586.
  38. DiMarco JP, Philbrick JT.  Use of ambulatory electrocardiographic (Holter) monitoring.  Ann Intern Med 1990;113:53-68.
  39. Zimetbaum PJ and Josephson ME.  The evolvin role of ambulatory arrhythmia monitoring in general practice.  Ann Intern Med 1999;130:848-856.
  40. Murakami Y, Okamoto M, Nakayama R.  Atrial late potential by P wave-triggered signal-averaged electrocardiogram and paroxysmal atrial fibrillation.  Nippon Rinsho 1995;53:489-495.
  41. Stafford PJ, Cooper J, Fothergill J, et al.  Reproducibility of the signal averaged P wave:  time and frequency domain analysis.  Heart 1997;77:412-416.
  42. Michelucci A, Padeletti L, Chelucci A, et al.  Influence of age, lead axis, frequency of arrhythmic episodes, and atrial dimensions on P wave triggered SAECG in patients with lone paroxysmal atrial fibrillation.  Pacing and Clinical Elctrophysiology 1996;19:758-767.
  43. Yamaguchi I, Kuga K, Sugishita Y, Ito I.  The signal-averaged electrocardiogram as a screening test for occurrence of paroxysmal atrial fibrillation.  J Am Coll Cardiol 1988;11:116A..
  44. Engel TR, Vallone N, Windle J.  Signal-averaged electrocardiograms in patients with atrial fibrillation or flutter.  Am Heart J 1988;115:592-597.
  45. Fukunami M, Yamada T, Ohmori M, et al.  Detection of patients at risk for paroxysmal atrial fibrillation during sinus rhythm by P wave-triggered signal-averaged electrocardiogram.  Circulation 1991;83:162-169.
  46. Koudstaal PJ, van Gijn J, Klootwuk APJ, et al.  Holter monitoring in patients with transient and focal ischemic attacks of the brain.  Stroke 1986;17:192-195.
  47. Britton M, de Faire U, Helmers C, et al.  Arrhythmias in patients with acute cerebrovascular disease.  Acta Med Scand 1979;205:425-428.
  48. Richardt G, Ensle G, Schwarz F, et al.  Diagnostik kardialer Ursachen zerebraler Embolien:  Beitrag von 2D-Echokardiographie und Langzeit-EKG.  Z Kardiol 1989;78:598-601.
  49. Norris JW, Froggatt GM, Hachinski VC.  Cardiac arrhythmias in acute stroke.  Stroke 1978;9:392-396.
  50. Rem JA, Hachinski VC, Boughner DR, Barnett HJM.  Value of cardiac monitoring and echocardiography in TIA and stroke patients.  Stroke 1985;16:950-956.
  51. Mikolich JR, Jacobs WC, Fletcher GF.  Cardiac arrhythmias in patients with acute cerebrovascular accidents.  JAMA 1981;246:1314-1317.
  52. Hornig CR, Haberbosch W, Lammers C, et al.  Specific cardiological evaluation after focal cerebral ischemia.  Acta Neurol Scand 1996;93:297-302.
  53. Lindgren A, Roijer A, Norrving B, et al.  Carotid artery and heart disease in subtypes of cerebral infarction.  Stroke 1994;25:2356-2362.
  54. Come PC, Riley MF, Bivas NK.  Roles of echocardiography and arrhythmia monitoring in the evaluation of patients with suspected systemic embolism.  Ann Neurol 1983;13:527-531.
  55. Tonet JL, Frank R, Ducardonnet A, et al.  L’enregistrement de Holter dans les acidents ischemiques cerebraux.  Nouv. Presse Med. 1981;10:2491-2494.
  56. Kessler DK, Kessler KM.  Is ambulatory electrocardiography useful in the evaluation of patients with recent stroke?  Chest 1995;107:916-918.
  57. Bogousslavsky J, Hachinski VC, Boughner DR, et al.  Cardiac and arterial lesions in carotid transient ischemic attacks.  Arch Neurol 1986;43:223-228.
  58. Kessler DK, Kessler KM, Myerburg RJ.  Ambulatory electrocardiography:  a cost per management decision analysis.  Arch Intern Med 1995;155:165-169.
  59. Connoly SJ, Laupacis A, Gent M, et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) study.  J Am Coll Cardiol 1991;18:349-355.
  60. The Atrial Fibrillation Investigators.  The efficacy of aspirin in patients with atrial fibrillation:  Analysis of pooled data from 3 randomized trials.  Arch Intern Med 1997;157:1237-1240.
  61. Laupacis A. Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5. Can J Cardiol. 1998 May; 14(5): 659,662-663.
  62. Mant MJ. Re: CJ Green, DC Hadorn, K Bassett, A Kazanjian. Anticoagulation in chronic nonvalvular atrial fibrillation: a critical appraisal and meta-analysis. 1997;13:811-5. Can J Cardiol. 1998 May; 14(5): 663.
  63. Levine MN, Hirsh J, Landefeld S, Raskob G.  Hemorrhagic complications of anticoagulant treatment.  Chest 1992;102 (suppl) :352S-363S.
  64. The Stroke Prevention in Atrial Fibrillation Investigators.  Bleeding during antithrombotic therapy in patients with atrial fibrillation.  Arch Intern Med 1996;156:409-416.
  65. Albers GW.  Atrial fibrillation and stroke: Three new studies, three remaining questions.  Arch Intern Med 1994;154:1443-1448.
  66. The European Atrial Fibrillation Trial Study Group.  Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.  N Engl J Med 1995;333:5-10.
  67. Harrison DC, Fitzgerald JW, Winkle RA.  Ambulatory electrocardiography for diagnosis and treatment of cardiac arrhythmias.  N Engl J Med 1976;294:373-380.
  68. Hankey GJ, Warlow CP.  Cost-effective investigation of patients with suspected transient ischaemic attacks.  J Neurol Neurosurg Psychiatry.  1992;55:171-176.
  69. Brown RD Jr, Evans BA, Wiebers DO, et al.  Transient ischemic attack and minor ischemic stroke:  An algorithm for evaluation and treatment.  Mayo Clin Proc 1994;69:1027-1039.
  70. Feinberg WM, Albers GW, Barnett HJM, et al.  Guidelines for the management of transient ischemic attacks.  Stroke 1994;25:1320-1335.


Canadian Journal of Neurological Sciences Abstract

Link to Structured Abstract of this review

Link to Summary Table of Recommendations of this review

Top of Page

Home PageCTFPHC Home Page

Reprinted in modified format by the Canadian Task Force on Preventive Health Care
with permission.
Original Copyright © 1999 Minister of Supply and Services Canada.
For any technical issues please contact: webmaster@ctfphc.org
Last modified: March 1, 2000.